Citeline, Trialtrove: 医療用医薬品の臨床試験情報データベース
25 Nov 2022
Our annual analysis dissects the data of all Phase I–III clinical trials that started in a year dominated by COVID-19.
Topic Coronavirus
Citeline
24 Oct 2022
Written by Daniel Chancellor, Thought Leadership and Consulting Director, Citeline
Citeline
13 Oct 2022
We witnessed all-time high trial volumes in 2021 and a new dominant force emerging in the clinical trial landscape. Learn more in our annual round-up.
Citeline
27 Jun 2022
Take a look at the evolution of pharma R&D and in this article, examine the state of play at the start of 2022.
Citeline
27 Jun 2022
Following on from our review of trends in the current pharmaceutical R&D pipeline, this supplement takes a look at the industry’s success stories of 2021 – the drugs which were launched onto the market for the first time during the year.
Citeline
27 Jun 2022
As the COVID-19 pandemic stretched through a second year, its impacts continued to reshape the clinical trials landscape.
Topic Clinical Trials
Citeline
27 Jun 2022
As the world begins its transition into a post-pandemic existence, it becomes possible to look back on the past two years and begin to quantify the effects that COVID-19 has brought.
Topic Clinical Trials
Citeline
02 Feb 2022
In our rare disease trial strategies whitepaper, see which sponsors lead the way, understand the geographical location of trials, and delve into the types of therapeutic area, plus much more.
Topic Rare Diseases
世界のパイプライン情報を徹底網羅, Trialtrove: 医療用医薬品の臨床試験情報データベース, Citeline,...
19 Aug 2021
Download your free infographic for a snapshot view of UK vs. EU4 clinical landscape
